Last updated on May 2019

Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

Brief description of study

The purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.

Clinical Study Identifier: NCT03732638

Find a site near you

Start Over

Wasatch Clinical Research, LLC

Salt Lake City, UT United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.